申请人:Nettekoven Matthias
公开号:US20100120769A1
公开(公告)日:2010-05-13
The present invention relates to compounds of formula I
wherein s, R
1a
and R
1
to R
3
are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
本发明涉及公式I的化合物,其中s,R1a和R1到R3如描述和权利要求中所定义,以及其药学上可接受的盐。这些化合物可用于治疗和/或预防与H3受体调节相关的疾病。